Does TOFACITINIB Cause Multiple sclerosis? 110 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Multiple sclerosis have been filed in association with TOFACITINIB (XELJANZ XR). This represents 0.1% of all adverse event reports for TOFACITINIB.
110
Reports of Multiple sclerosis with TOFACITINIB
0.1%
of all TOFACITINIB reports
1
Deaths
22
Hospitalizations
How Dangerous Is Multiple sclerosis From TOFACITINIB?
Of the 110 reports, 1 (0.9%) resulted in death, 22 (20.0%) required hospitalization.
Is Multiple sclerosis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TOFACITINIB. However, 110 reports have been filed with the FAERS database.
What Other Side Effects Does TOFACITINIB Cause?
Drug ineffective (30,382)
Pain (21,659)
Condition aggravated (16,925)
Arthralgia (15,640)
Fatigue (13,551)
Rheumatoid arthritis (12,277)
Off label use (11,736)
Headache (11,061)
Joint swelling (10,686)
Malaise (9,040)
What Other Drugs Cause Multiple sclerosis?
DIMETHYL (5,074)
NATALIZUMAB (4,078)
INTERFERON BETA-1A (3,412)
OCRELIZUMAB (2,609)
GLATIRAMER (2,596)
DALFAMPRIDINE (2,224)
FINGOLIMOD (2,123)
TERIFLUNOMIDE (1,983)
OFATUMUMAB (1,267)
DIROXIMEL (978)
Which TOFACITINIB Alternatives Have Lower Multiple sclerosis Risk?
TOFACITINIB vs TOFERSEN
TOFACITINIB vs TOLNAFTATE
TOFACITINIB vs TOLODODEKIN ALFA
TOFACITINIB vs TOLTERODINE
TOFACITINIB vs TOLVAPTAN